|
시장보고서
상품코드
2091653
무세포 단백질 합성 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 용도별, 최종사용자별, 발현 시스템별, 워크플로우별, 제품 형태별, 지역별 - 업계 예측(2026-2033년)Cell Free Protein Synthesis Market Size, Share, and Growth Analysis, By Product Type, By Application, By End User, By Expression System, By Workflow, By Product Format, By Region - Industry Forecast 2026-2033 |
||||||
세계의 무세포 단백질 합성 시장 규모는 2024년에 3억 4,000만 달러로 평가되며, 2025년 3억 7,094만 달러에서 2033년까지 7억 4,456만 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 9.1%로 성장할 것으로 전망되고 있습니다.
전 세계 무세포 단백질 합성 시장은 살아있는 세포 없이도 체외(in vitro)에서 단백질 생산을 가능하게 하는 혁신적인 플랫폼으로 구성되어 있으며, 추출물이나 재조합 시스템을 활용하여 유전적 템플릿의 번역 과정을 촉진합니다. 이 시장은 신약 개발을 촉진하고, 독성 단백질을 생성하며, 기존의 세포배양에서 따르는 복잡성 없이 생물제제의 프로토타입 제작을 가능하게 하는 데 있으며, 매우 중요한 역할을 하고 있습니다. 밀 배아나 대장균(E. coli) 용해물 등의 기술을 도입함으로써 비용이 대폭 절감되고 수율이 향상되었으므로 고처리량 스크리닝에서 선호되는 기법이 되었습니다. 특히 백신 및 치료용 항체 개발 분야에서 분산형 바이오의약품 생산에 대한 수요가 증가하고 있는 것이 시장 성장을 주도하고 있습니다. 또한 AI를 활용한 자동화를 통해 합성 효율이 비약적으로 향상되고, 최적 조건이 예측되며, 워크플로우가 효율화되고 있으며, 이로 인해 해당 분야의 확대와 함께 생명공학 기업에게 있으며, 그 매력이 높아지고 있습니다.
세계 무세포 단백질 합성 시장 촉진요인
맞춤형 의료에 대한 관심이 높아지고 있는 데다, 신속한 백신 개발에 대한 시급한 수요까지 더해지면서 무세포 단백질 합성에 대한 관심이 크게 높아지고 있습니다. 이 기술을 통해 생세포 없이도 표적 단백질을 효율적으로 생산할 수 있으므로, 개발 기간을 단축할 수 있고, 연구자들은 새로운 건강 문제에 대응하여 접근 방식을 신속하게 적용하고 개선할 수 있게 됩니다. 이러한 유연성 덕분에, 신속하고 범용성이 높은 생산 방식을 우선시하는 제약 회사와 생명공학 기업 사이에서 이 기술에 대한 수용이 확대되고 있습니다. 또한 지금까지 활용되지 않았던 단백질을 생성할 수 있는 능력 덕분에 활용 가능한 표적의 범위가 확대되면서, 연구 분야와 상업 분야 모두에서 무세포 기술에 대한 투자가 증가하고 있습니다.
세계 무세포 단백질 합성 시장의 제약 요인
고순도 뉴클레오티드, 아미노산 및 특수 라이세이트에 대한 수요가 높기 때문에 무세포 단백질 합성에 필요한 초기 투자 비용이 크게 증가하여 소규모 연구소나 신흥 시장에게는 진입 장벽이 되고 있습니다. 이러한 재정적 장벽은 광범위한 실험을 방해하고, 창업한 지 얼마 되지 않은 기업이 이 기술을 자사의 공정에 도입하는 것을 제한하는 경우가 많아, 결과적으로 시장 전체의 성장을 저해하고 있습니다. 그 결과, 예산이 제한된 조직은 초기 비용이 비교적 낮은 기존의 발현 시스템을 선호하는 경향이 있으며, 이로 인해 무세포 플랫폼의 도입 속도가 더욱 더뎌지고 있습니다. 또한 표준화된 키트가 부족하여 조달난이 심화되고 있으며, 잠재적 사용자들이 시장에 진입하기가 더욱 어려워지고 있습니다.
세계 무세포 단백질 합성 시장의 동향
전 세계 무세포 단백질 합성 시장은 맞춤형 의료의 확대를 원동력으로 삼아 인상적인 성장을 달성하고 있습니다. 맞춤형 의료로의 전환에 따라 독자적인 유전자 프로파일에 맞춘 신속하고 맞춤형 단백질 합성에 대한 수요가 증가하고 있습니다. 무세포 합성 플랫폼은 기존의 세포배양에 수반되는 장기간의 공정을 배제하고, 오염 위험을 최소화하면서 신속한 반복 주기를 가능하게 하는 효율적인 접근 방식을 제공합니다. 생명공학 기업이 적응성이 높은 제조 방안을 모색하는 가운데, 개념 증명(PoC) 연구를 강화하고 환자 맞춤형 치료법 개발을 촉진하는 동시에 확장성 향상, 환경 영향 저감, 그리고 엄격한 품질관리 조치 확보를 도모하기 위해 무세포 시스템에 대한 관심이 높아지고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 무세포 단백질 합성 시장 규모 : 제품 유형별
세계의 무세포 단백질 합성 시장 규모 : 용도별
세계의 무세포 단백질 합성 시장 규모 : 최종사용자별
세계의 무세포 단백질 합성 시장 규모 : 발현 시스템별
세계의 무세포 단백질 합성 시장 규모 : 워크플로우별
세계의 무세포 단백질 합성 시장 규모 : 제품 형태별
세계의 무세포 단백질 합성 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.07.23Global Cell Free Protein Synthesis Market size was valued at USD 340.0 Million in 2024 and is poised to grow from USD 370.94 Million in 2025 to USD 744.56 Million by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).
The global cell-free protein synthesis market consists of innovative platforms that facilitate protein production in vitro without the need for living cells, utilizing extracts or recombinant systems to expedite the translation of genetic templates. This market plays a pivotal role in advancing drug discovery, enabling the creation of toxic proteins, and facilitating biologic prototyping without the complexities of traditional cell culture. The adoption of technologies such as wheat germ and E. coli lysates has significantly reduced costs and enhanced yields, making it a preferred method for high-throughput screening. The rising demand for decentralized biologics production, especially in vaccine and therapeutic antibody development, drives market growth. Additionally, AI-driven automation is revolutionizing synthesis efficiency, predicting optimal conditions, and streamlining workflows, thus supporting the sector's expansion and attractiveness to biotech firms.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Free Protein Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cell Free Protein Synthesis Market Segments Analysis
Global cell free protein synthesis market is segmented by product type, application, end user, expression system, workflow, product format and region. Based on product type, the market is segmented into Cell-free Expression Systems, Reagents & Kits, Enzymes & Extracts, Cell-free Biomanufacturing Platforms and Custom Protein Synthesis Services. Based on application, the market is segmented into Protein Engineering, Therapeutic Protein Development, Antibody Discovery, Enzyme Production, Synthetic Biology, Vaccine Research, Functional Genomics and Others. Based on end user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations. Based on expression system, the market is segmented into Prokaryotic Systems, Eukaryotic Systems and Hybrid Systems. Based on workflow, the market is segmented into Research Use, Process Development and Commercial Manufacturing. Based on product format, the market is segmented into Kits, Reagents, Instruments and Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Cell Free Protein Synthesis Market
The growing focus on personalized medicine, coupled with the pressing demand for rapid vaccine development, has significantly increased interest in cell-free protein synthesis. This technology allows for the efficient production of target proteins without the need for live cells, resulting in reduced development times and enabling researchers to quickly adapt and refine their approaches in response to new health challenges. Such flexibility promotes wider acceptance within pharmaceutical and biotech firms that prioritize swift and versatile production methods. Additionally, the ability to generate previously untapped proteins expands the range of available targets, leading to increased investment in cell-free technologies within both research and commercial domains.
Restraints in the Global Cell Free Protein Synthesis Market
The high demand for pure nucleotides, amino acids, and specialized lysates significantly increases the initial investment needed for cell-free protein synthesis, creating a barrier for small-scale labs and emerging markets. This financial hurdle often deters extensive experimentation and restricts early-stage companies from integrating this technology into their processes, thereby hindering its overall market growth. As a result, organizations with limited budgets tend to prefer traditional expression systems that require lower upfront costs, further slowing the adoption rate of cell-free platforms. Additionally, the lack of standardized kits exacerbates procurement difficulties, making it even more challenging for potential users to enter the market.
Market Trends of the Global Cell Free Protein Synthesis Market
The Global Cell Free Protein Synthesis market is experiencing significant growth fueled by the expansion of personalized therapeutics. The shift towards personalized medicine has generated a heightened demand for rapid, customized protein synthesis that aligns with unique genetic profiles. Cell-free synthesis platforms provide a streamlined approach, eliminating the lengthy processes associated with traditional cell culture and allowing for quicker iteration cycles with minimal contamination risks. As biotechnology companies pursue adaptable manufacturing options, they are increasingly turning to cell-free systems to enhance proof-of-concept investigations and facilitate the development of patient-specific treatments, all while promoting scalability, reducing environmental impact, and ensuring stringent quality control measures.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Cell Free Protein Synthesis Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Cell-free Expression Systems
- Reagents & Kits
- Enzymes & Extracts
- Cell-free Biomanufacturing Platforms
- Custom Protein Synthesis Services
Global Cell Free Protein Synthesis Market Size by Application & CAGR (2026-2033)
- Market Overview
- Protein Engineering
- Therapeutic Protein Development
- Antibody Discovery
- Enzyme Production
- Synthetic Biology
- Vaccine Research
- Functional Genomics
- Others
Global Cell Free Protein Synthesis Market Size by End User & CAGR (2026-2033)
- Market Overview
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
Global Cell Free Protein Synthesis Market Size by Expression System & CAGR (2026-2033)
- Market Overview
- Prokaryotic Systems
- Eukaryotic Systems
- Hybrid Systems
Global Cell Free Protein Synthesis Market Size by Workflow & CAGR (2026-2033)
- Market Overview
- Research Use
- Process Development
- Commercial Manufacturing
Global Cell Free Protein Synthesis Market Size by Product Format & CAGR (2026-2033)
- Market Overview
- Kits
- Reagents
- Instruments
- Services
Global Cell Free Protein Synthesis Market Size & CAGR (2026-2033)
- North America (Product Type, Application, End User, Expression System, Workflow, Product Format)
- US
- Canada
- Europe (Product Type, Application, End User, Expression System, Workflow, Product Format)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Application, End User, Expression System, Workflow, Product Format)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Application, End User, Expression System, Workflow, Product Format)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Application, End User, Expression System, Workflow, Product Format)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- LenioBio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synthelis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cube Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arbor Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Jena Bioscience
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GeneFrontier Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CellFree Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- New England Biolabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biotechrabbit
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NZYTech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioneer Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nanotherics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Profacgen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Creative Biolabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Daicel Arbor Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synvitrobio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rapid Novor
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Codex DNA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
